Genome Editing/Genome Engineering Market - Global Forecast to 2021 - Increasing Demand for Synthetic Genes - Research and Markets

DUBLIN, October 17, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Genome Editing/Genome Engineering Market - Global Forecast to 2021" report to their offering.

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing a significant transformation, with the changing landscapes of healthcare, and manufacturing industries. The growth of this market is majorly influenced by the dynamics of these industries.

Factors such as rising government funding and growth in the number of genomics projects, high prevalence rate of infectious diseases and cancer among patients, technological advancements, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the genome editing market in the coming years. Rise in the production of genetically modified crops is also expected to increase the demand for genome editing. However, the high cost of genomic equipment, shortage of trained professionals, and adverse public perception related to genetic research are restraining the growth of the market to a certain extent.

Increasing use of genome editing in specialized/personalized medicine and emerging markets in developing countries like Brazil, China, and India are providing various growth opportunities for players in the genome editing market.

In 2016, North America is expected to account for the largest share of the global genome editing market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is also projected to have the highest growth rate in the forecast period. Factors such as the development of gene therapy in the U.S.; increasing use of GM crops; prevalence of Alzheimer's disease, dementia, infectious diseases, and cancer in the U.S.; growing availability of research grants and funding, and genome editing standards workshops and conferences are likely to propel the market in North America.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, partnerships, and funding; patent approval to increase their market shares and establish a strong foothold in the global market.  

Companies Mentioned:

• Genscript Usa Inc.
• Horizon Discovery Group Plc
• Integrated Dna Technologies, Inc.
• Lonza Group Ltd.
• Merck Kgaa
• New England Biolabs, Inc.
• Origene Technologies, Inc.
• Sangamo Biosciences, Inc.
• Thermo Fisher Scientific, Inc.
• Transposagen Biopharmaceuticals, Inc.
  

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Global Genome Editing/Engineering Market, By Technology

7 Global Genome Editing/Genome Engineering Market, By Application

8 Global Genome Editing/Engineering Market, By End User

9 Genome Editing/Genome Engineering Market, By Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

For more information about this report visit http://www.researchandmarkets.com/research/8zn2d6/genome

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716